搜索

购物车()
首页> 生物试剂
Fluorescent Human ES/iPS Cell Characterization Kit
  • 商城价格 登录后可查看价格
  • 货号 SCR078
  • 品牌 Merck millipore/默克密理博 ( 一级代理 )
  • CAS号 见包装
  • 规格/包装 1KIT
  • 单位
  • 储存条件 见包装
  • 现货状态 询货

  • 数量

    - +

    成功收藏产品
  • 立即购买
商家描述 售后服务 商家资质信息 产品评价(0)
Human embryonic stem (hES) cells are pluripotent cells derived from the inner cell mass of pre-implantation blastocysts. Human induced pluripotent (hiPS) cells are pluripotent cells generated by reprogramming human somatic cells using four transcription factors, Oct-4, Klf-4, Sox-2, and c-Myc, or their variants. Both hESC and hiPSC can self-renew and have the ability to generate all three germ layers: ectoderm, mesoderm, and endoderm. In vitro, hESC/iPSC are normally maintained and propagated on mouse fibroblast feeders for extended periods in media containing basic fibroblast growth factor (bFGF). However, spontaneous differentiation may occur in subpopulations of cells. Several pluripotent markers are commonly used to distinguish pluripotent hESC/iPSC from differentiated cells.EMD Millipore’s Fluorescent Human ES/iPS Cell Characterization Kit contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human ES/iPS cells. Included in the kit is an enzymatic assay to measure alkaline phosphatase activity in the cells along with validated directly conjugated antibodies to pluripotent transcription factors, Oct-4, Sox-2 and Nanog and cell surface epitopes TRA-1-60 and TRA-1-81 to enable rapid immunocytochemical marker analysis. The Dapi nuclear dye is conveniently included to aid in cell quantification. While the expression levels of pluripotent markers are expected to be diminished upon differentiation, each possess specific expression kinetics. For example, it has been noted that upon differentiation, Oct-4 and TRA-1-60 expressions are the first to be down-regulated while Nanog and alkaline phosphatase down-regulate at a much slower timeframe.,官网链接:https://www.sigmaaldrich.cn/product/mm/scr078 默克 科研、开发、生产。 作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。
返回顶部